Norfloxacin: a new quinolone. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.
D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004247:DNA / Q000187:drug effects; D006801:Humans; D009643:Norfloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000188:drug therapy
D004247:DNA; D009643:Norfloxacin